These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32402357)

  • 1. Advances in the Treatment of Stage III Non-Small Cell Lung Cancer.
    Myall NJ; Das M
    Clin Chest Med; 2020 Jun; 41(2):211-222. PubMed ID: 32402357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer.
    Melosky B; Juergens R; McLeod D; Leighl N; Brade A; Card PB; Chu Q
    Lung Cancer; 2019 Aug; 134():259-267. PubMed ID: 31319991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmet Clinical Need in the Management of Locally Advanced Unresectable Lung Cancer: Treatment Strategies to Improve Patient Outcomes.
    Rajappa S; Sharma S; Prasad K
    Adv Ther; 2019 Mar; 36(3):563-578. PubMed ID: 30693419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria.
    Sakaguchi T; Ito K; Furuhashi K; Nakamura Y; Suzuki Y; Nishii Y; Taguchi O; Hataji O
    Respir Investig; 2019 Sep; 57(5):466-471. PubMed ID: 31104989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer.
    Cheema PK; Rothenstein J; Melosky B; Brade A; Hirsh V
    Curr Oncol; 2019 Feb; 26(1):37-42. PubMed ID: 30853796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction Immunotherapy Followed by Thoracic Radiation without Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Case Series.
    Dasari S; Komiya T
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):217-220. PubMed ID: 35092391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing landscape of stage III lung cancer: a literature review.
    Patel M; Bruno D; Grubb W; Biswas T
    Expert Rev Anticancer Ther; 2020 Aug; 20(8):675-686. PubMed ID: 32667262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.
    Shimada Y; Suzuki K; Okada M; Nakayama H; Ito H; Mitsudomi T; Saji H; Takamochi K; Kudo Y; Hattori A; Mimae T; Aokage K; Nishii T; Tsuboi M; Ikeda N
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):895-901. PubMed ID: 27543652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case report.
    Nishino K; Kunimasa K; Kimura M; Inoue T; Tamiya M; Kuhara H; Kumagai T
    BMC Pharmacol Toxicol; 2020 Apr; 21(1):26. PubMed ID: 32245391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
    Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
    Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
    Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Ramnath N; Dilling TJ; Harris LJ; Kim AW; Michaud GC; Balekian AA; Diekemper R; Detterbeck FC; Arenberg DA
    Chest; 2013 May; 143(5 Suppl):e314S-e340S. PubMed ID: 23649445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of immunotherapy in stage III nonsmall cell lung cancer.
    Wrona A
    Curr Opin Oncol; 2019 Jan; 31(1):18-23. PubMed ID: 30489337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancer.
    Shaverdian N; Offin MD; Rimner A; Shepherd AF; Wu AJ; Rudin CM; Hellmann MD; Chaft JE; Gomez DR
    Radiother Oncol; 2020 Mar; 144():101-104. PubMed ID: 31786421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality therapy for non-small cell lung carcinoma.
    Machtay M; Glatstein E
    Cancer J; 2002; 8 Suppl 1():S55-67. PubMed ID: 12075703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durvalumab for the treatment of non-small cell lung cancer.
    Murakami S
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1009-1016. PubMed ID: 31782989
    [No Abstract]   [Full Text] [Related]  

  • 17. Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience.
    Botticella A; Mezquita L; Le Pechoux C; Planchard D
    Ther Adv Respir Dis; 2019; 13():1753466619885530. PubMed ID: 31686616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates in Local-Regionally Advanced Non-Small Cell Lung Cancer.
    Tsao AS; Jolly S; Lee JM
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():553-562. PubMed ID: 31099691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined modality treatment of non-small-cell lung cancer.
    Westeel V; Depierre A
    Am J Respir Med; 2003; 2(6):477-90. PubMed ID: 14719987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.